Business Context and Reporting Period
Company: National Healthcare Properties, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 30, 2026
Principal Event: Completion of a registered underwritten public offering of Class A common stock and entry into an Amended and Restated Agreement of Limited Partnership.
Key Financial Metrics
This filing is a current report regarding corporate actions and does not contain audited financial statements, revenue, profit, cash flow, or margin data for the period.
- Capital Raised: The filing details the sale of 38,500,000 shares of Class A common stock, with an additional 5,775,000 Option Shares purchased by underwriters to cover overallotments. The total shares issued were 44,275,000.
- Offering Dates: Primary offering closed April 23, 2026; Option Shares closed April 28, 2026.
- Debt and Liquidity: The filing text does not provide specific values for debt levels, liquidity ratios, or cash balances.
Material Changes Versus Prior Period
The filing reports significant structural and capitalization changes effective April 30, 2026:
- Capital Structure: Issuance of 44,275,000 shares of Class A common stock.
- Partnership Agreement: Execution of an Amended and Restated Agreement of Limited Partnership (A&R OP Agreement) which:
- Removed references to special limited partnership interests held by Healthcare Trust Special Limited Partnership, LLC (which crystallized with no value).
- Converted all outstanding Class B Units into common limited partnership units (OP Units).
- Eliminated Class B Units as an issuable class.
- Reset the exchange factor for converting OP Units to common stock to 1.0.
- Established a new class of units designated as "LTIP Units" (including Basic and Performance sub-classes).
Guidance, Outlook, and Management Commentary
The filing does not contain forward-looking guidance, revenue outlook, or management commentary regarding future financial performance.
Compensatory Arrangements:
- Employee Awards: 995,994 shares of common stock and LTIP Units granted to employees and named executive officers, vesting annually in 25% increments starting April 30, 2027.
- Executive Grants: Michael Anderson (CEO) received 348,665 LTIP Units; Andrew T. Babin (CFO) received 149,428 LTIP Units; Ailin Park (CAO) received 25,000 LTIP Units.
- Director Awards: 12,500 restricted shares and/or LTIP Units authorized for each director.
Important Facts for Investor Verification
- Verify the final offering price per share and total net proceeds from the 44,275,000 shares issued, as these figures are not explicitly stated in the text of this 8-K.
- Review the full text of the Amended and Restated Agreement of Limited Partnership (to be filed as an exhibit to the Form 10-Q for the quarter ended March 31, 2026) for detailed terms on redemption rights and LTIP Unit mechanics.
- Confirm the impact of the 1.0 exchange factor reset on the conversion of existing OP Units held by limited partners.
- Monitor the vesting schedule and potential dilution effects of the 995,994 equity awards granted to executives and employees.